Suzhou Fushilai Pharmaceutical (301258.SZ) plans to spend 20 million to 40 million yuan on implementing a buyback.

Suzhou Fushilai Pharmaceutical (301258.SZ) announced that the company plans to use its own funds to repurchase company shares, which will be used at a suitable time in the future for implementing equity incentive plans or employee stock ownership plans. The total amount of funds for repurchasing shares shall be no less than 20 million yuan and shall not exceed 40 million yuan. The price for repurchasing shares shall not exceed 40.00 yuan per share (inclusive). The implementation period for repurchasing shares shall be within 12 months from the date of approval by the company's board of directors of this repurchase plan.